Insights

Introduction: The Patent Filing Is a Financial Document The global prescription drug market cleared $1.6 trillion in annual revenue by […]

The $236 Billion Opportunity Generic drugs fill roughly 90% of all U.S. prescriptions but account for only about 22% of

1. The Anatomy of a U.S. Drug Patent: Knowing the Battlefield The dominant narrative in pharmaceutical IP for most of

Chronic diseases kill 74% of all humans who die each year. That is not a warm-up statistic—it is the entire

Generic medicines fill 89% of all U.S. prescriptions yet account for only 26% of total drug spend. That ratio defines

The $400 Billion Ticking Clock: Quantifying the Patent Cliff Between 2025 and 2030, the global pharmaceutical industry faces a Loss

Executive Market Assessment: The Sovereign Paradox The Russian pharmaceutical sector currently operates within a paradigm of aggressive state-managed isolationism, creating

For pharma IP teams, portfolio managers, R&D leads, and institutional investors navigating the $300 billion patent cliff 1. The Strategic

The global pharmaceutical industry is running out of time. Between 2024 and 2030, roughly $200 billion in branded drug revenue